Location: Home
  • search
  • go
  • Relate News
  • 8/25/2023Domestic Pharma Sealed Ten Outlicensing Deals in H1/2023 (Updated)
  • 8/25/2023IQVIA: Overall Chinese Pharma Market Growth Up 0.3% in 2022
  • 8/25/2023State Council Adopts New Action Plan for High-quality Development of P...
  • 8/25/2023China: The Latest Medtech Access Policies and Implications
  • 8/24/2023Review of China Performance of Leading MNCs in China H1/2023 (Updated)
  • 8/24/2023CMS Licenses China Rights of Class 1 Anti-Ischemic Stroke New Drug fro...
  • 8/23/2023What China's New Patent Linkage and Patent Term Extension Systems Mean...
  • 8/23/2023Increasingly, State Investment and Middle Eastern Sovereign Wealth Are...
  • 8/22/2023Brand-Name Drugs Feel the Squeeze in China's Generic-Heavy Market (Pod...
  • 8/22/2023Simcere, MabTech Inks Collaborative Agreement for CMAB009 in Mainland ...
  • 8/21/2023Moderna and CARsgen Join Forces to Combine mRNA Cancer Vaccine with CA...
  • 8/18/2023NHSA Publicizes the List of Drugs Passing Preliminary Form Evaluation ...
  • 8/18/2023Recent Executive Moves
  • 8/17/2023NMPA Revises the Information Standard System for Drug Regulatory Digit...
  • 8/16/2023Biocytogen Pharma Announces Opening of Waltham, MA Facility
  • 8/16/2023Chinese Drugmakers Develop Copycat Versions of 'Miracle' Weight-Loss D...
  • 8/15/2023Aurisco Pharma's Plant in Yangzhou Passes USFDA Inspection
  • 8/14/2023China Introduces New Policy to Boost Foreign Investment, Highlighting ...
  • 8/14/2023China's Medicine and Health Product Trade Down in H1/2023 as World Mov...
  • 8/14/2023China's Economy Is Showing Signs of Serious Trouble — And the Problem...
  • 8/11/2023China's Sitting on a Goldmine of Genetic Data – and It Doesn't Want t...
  • 8/11/2023Recent Executive Moves
  • 8/9/2023Novartis Responds to Hospital's Staff Dismissal Recommendation Amid Ch...
  • 8/8/2023AstraZeneca Strikes mRNA Vaccine Deal with China's CanSino
  • 8/8/2023BioNTech and Beigene Ink New Licensing Deals While AbbVie and Novartis...
  • 8/7/2023Chia-Tai Tianqing Pharma and Inventisbio Enter into Exclusive Licens...
  • 8/7/2023BMS and BeiGene Settle Disputes by Terminating Legacy Celgene Licensin...
  • 8/3/2023MSD Overtakes AZ as the Top Pharma MNC in China Backed by Robust Growt...
  • 8/3/2023Oramed and HTIT Form JV for Oral Insulin Medications
  • 8/3/2023Mundipharma Reconsiders China Business Sale Amid Surging Interest from...
  • Page:20/333 Total number of articles:9989: [First][<<] [18] [19] [20] [21] [22] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group